Navigation Links
Phase Genomics Announces Commercial Availability of Rapid End-to-End Genome Assembly Service
Date:1/14/2017

Seattle-based Phase Genomics has announced the general availability of Proximo™, a new service providing complete end-to-end genome assemblies to researchers around the globe. Long considered a “holy grail” in biological research, access to complete genomes eliminates a major obstacle in answering a wide range of scientific questions. The announcement was made today at the Plant & Animal Genome Conference (PAGXXV) in San Diego.

“After receiving very positive responses from our initial customer engagements, we are thrilled to bring this solution to the broader market.” said Dr. Ivan Liachko, CEO and Co-founder of Phase Genomics. “We believe Proximo represents a fundamental advancement in genome assembly technology that will help researchers in a variety of fields.”

Creating a complete or “chromosome-scale” reference genome for an organism is akin to completing the genetic blueprint for that species. Previously, most genome sequencing and assembly technologies left genomes in many pieces, obscuring significant information about the biology of an organism. Making a complete genome requires grouping and arranging hundreds or thousands of DNA sequences properly, a highly laborious, expensive, nearly impossible task with traditional tools. In practice, these assembly methods leave most genome assemblies highly fragmented, much like unfinished jigsaw puzzles.

To overcome this obstacle, Phase Genomics developed a new approach to measure the distances between DNA sequences using a modified version of the popular chromosome conformation capture method, Hi-C. These measurements allow the company’s software to organize DNA sequence fragments into whole chromosomes.

“We had tried all of these other genome assembly technologies,” said Prof. Mitch McGrath of Michigan State University, who studies sugar beets and agricultural productivity. “Then Phase Genomics used Proximo at the final step to make 9 complete scaffolds for 9 sugar beet chromosomes – exactly where I wanted to be. I almost fell off my chair when I saw it. It’s very exciting.”

Interested parties can learn more about Proximo and other Phase Genomics services by visiting their booth at the Plant & Animal Genome Conferece (PAGXXV) or by visiting Phase Genomics their website at http://www.phasegenomics.com.

Read the full story at http://www.prweb.com/releases/2017/01/prweb13984457.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Symbios Announces National Science Foundation SBIR Phase IIB Award to Commercialize Plasma Oxidation Technology
2. Vtesse Announces Dosing of First Patient in Australia in Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease
3. Recombinant Technologies, LLC, Receives Phase II SBIR Grant to Develop AmyTrap for Treatment of Alzheimer’s Disease
4. AOBiome Launches Phase 2 Clinical Trial Using Novel Bacterial Platform for Treatment of Hypertension
5. Soligenix Announces Positive Long-Term Follow-up Results from its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
6. Soligenix Announces Investor Webcast Event: Origins of Innate Defense Regulators and Review of the SGX942 Phase 2 Study Results in Oral Mucositis
7. ACEA Biosciences Presents Efficacy and Safety Data From AC0010 Phase I/II Clinical Trial for Treatment of Advanced Non-Small Cell Lung Cancer at the WCLC 2016 Conference
8. Nordion and General Atomics Welcome US National Nuclear Security Administration Phase II Funding for New, Reliable Source of Molybdenum-99
9. Lycera Announces Initiation of Phase 2 UPRISE Clinical Trial of LYC-30937-EC for Patients with Moderate Psoriasis
10. Axovant to Present Patient Function and Independence Data Analyses from Phase 2b Study of Investigational Treatment Intepirdine in Alzheimers Disease at CTAD 2016
11. Resverlogix Announces Second Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone (RVX-208)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... and OXFORD, England , Aug. 16, 2017 ... for biotech executive search and leadership development, and Virdis Group, ... have created an exclusive alliance that enables clients to leverage ... "For our clients here in the ... access to a diverse population of leadership talent throughout the ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... pharmaceutical and biotherapeutics development, announces the launch of the new NHS Agile ... gain kinetic binding data for a wide range of molecules, including small and ...
(Date:8/15/2017)... ... 15, 2017 , ... Kenall, a leader in sealed solid-state ... tightly sealed and perform efficiently for years. The downlights are ideal for a ... enough, such as: hospitals; behavioral health facilities; cleanrooms; containment areas; food and pharmaceutical ...
(Date:8/15/2017)... ... August 15, 2017 , ... JULABO USA introduces ... the new website makes it easy to navigate through the site whether you’re ... find detailed product information, educational industry content and visit the company’s social media ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
Breaking Biology News(10 mins):